We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+11.6%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$169M
AUM Growth
-$76.8M
Cap. Flow
-$93.2M
Cap. Flow %
-55.03%
Top 10 Hldgs %
46.89%
Holding
105
New
8
Increased
16
Reduced
63
Closed
15

Top Buys

Rank Stock Value
1
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$1.53M
2
LEGN icon
Legend Biotech
LEGN
+$1.34M
3
ZLAB icon
Zai Lab
ZLAB
+$1.34M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$1.18M
5
BPMC
Blueprint Medicines
BPMC
+$1.1M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$11.2M
2
UNH icon
UnitedHealth
UNH
+$7.66M
3
MRK icon
Merck
MRK
+$7.43M
4
ABBV icon
AbbVie
ABBV
+$5.44M
5
ABT icon
Abbott
ABT
+$5.14M

Sector Composition

Rank Sector Weight
1 Healthcare 99.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLS
76
DELISTED
Apellis Pharmaceuticals
APLS
$297K 0.18%
10,300
-160
-2% -$5.92K
CRNX icon
77
Crinetics Pharmaceuticals
CRNX
$8.84B
$296K 0.18%
5,800
– –
RVMD icon
78
Revolution Medicines
RVMD
$39.9B
$292K 0.17%
6,430
-170
-3% -$7.4K
TSBX
79
DELISTED
Turnstone Biologics
TSBX
$288K 0.17%
517,648
– –
EXEL icon
80
Exelixis
EXEL
$13.3B
$286K 0.17%
11,010
-450
-4% -$11.2K
PTCT icon
81
PTC Therapeutics
PTCT
$5.68B
$282K 0.17%
7,600
+3,300
+77% +$110K
CATX icon
82
Perspective Therapeutics
CATX
$332M
$272K 0.16%
20,400
+9,400
+85% +$125K
NVO
83
Novo Nordisk
NVO
$208B
$262K 0.15%
+2,200
New +$293K
JAZZ icon
84
Jazz Pharmaceuticals
JAZZ
$15.9B
$253K 0.15%
2,274
-1,060
-32% -$116K
MDGL icon
85
Madrigal Pharmaceuticals
MDGL
$10.8B
$222K 0.13%
1,045
-20
-2% -$5.12K
GERN icon
86
Geron
GERN
$828M
$209K 0.12%
+46,000
New +$209K
ITOS
87
DELISTED
iTeos Therapeutics
ITOS
$160K 0.09%
15,650
-81,316
-84% -$1.24M
JPST icon
88
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
$127K 0.07%
+2,500
New +$126K
ADCT icon
89
ADC Therapeutics
ADCT
$134M
$114K 0.07%
36,214
-191,888
-84% -$605K
KYTX icon
90
Kyverna Therapeutics
KYTX
$444M
$112K 0.07%
22,900
+15,900
+227% +$123K
ALKS icon
91
Alkermes
ALKS
$8.22B
– –
-16,730
Closed -$403K
ARWR icon
92
Arrowhead Research
ARWR
$11.9B
– –
-7,522
Closed -$195K
BDX icon
93
Becton Dickinson
BDX
$45.6B
– –
-4,000
Closed -$935K
BHVN icon
94
Biohaven
BHVN
$2.03B
– –
-3,900
Closed -$135K
CI icon
95
Cigna
CI
$73.7B
– –
-3,500
Closed -$1.16M
ELV icon
96
Elevance Health
ELV
$81.5B
– –
-4,500
Closed -$2.44M
HALO icon
97
Halozyme
HALO
$9.79B
– –
-3,815
Closed -$200K
INCY icon
98
Incyte
INCY
$24.2B
– –
-8,905
Closed -$540K
PGNY icon
99
Progyny
PGNY
$2.44B
– –
-70,000
Closed -$2M
PODD icon
100
Insulet
PODD
$11.5B
– –
-7,350
Closed -$1.48M
1 2 3
4
5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Sectoral Asset Management held 105 positions worth $169M, down 31% from $246M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sectoral Asset Management withdrew a net $93.2M in Q3 2024, closing 15 positions and reducing 63 holdings. Its most notable exit was Elevance Health, an estimated $2.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in iShares 0-3 Month Treasury Bond ETF worth $1.53M.

  • Sectoral Asset Management's largest Q3 2024 buy was iShares 0-3 Month Treasury Bond ETF: 15,200 shares worth $1.53M.
  • Sectoral Asset Management added most to Legend Biotech in Q3 2024, an estimated $1.34M increase.
  • Sectoral Asset Management's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $11.2M.
  • Sectoral Asset Management fully exited Elevance Health in Q3 2024, selling an estimated $2.44M.
  • Sectoral Asset Management's ten largest holdings make up 47% of its $169M portfolio in Q3 2024.
  • Sectoral Asset Management opened 8 new positions and closed 15 in Q3 2024.
  • Sectoral Asset Management's portfolio value fell 31% quarter-over-quarter to $169M.

Based on Sectoral Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.